Quanterix Corporation logo

Quanterix Corporation share price today

(QTRX)

Quanterix Corporation share price is $11.79 & ₹998.44

$11.79

-0.75

(-5.98%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Quanterix Corporation share price in Dollar and Rupees. Guide to invest in Quanterix Corporation from India. Also see the sentimental analysis on Indian investors investing in Quanterix Corporation. Get details on the Indian mutual funds that are investing in Quanterix Corporation. Get Analyst recommendations and forecasts along with all the Quanterix Corporation's financials.

Quanterix Corporation share price movements

  • $11.78
    $12.50

    Day's Volatility :5.76%

  • $10.50
    $29.70

    52 Weeks Volatility :64.65%

Quanterix Corporation Returns

PeriodQuanterix CorporationSector (Health Care)Index (Russel 2000)
3 Months
1.87%
-6.2%
0.0%
6 Months
-18.36%
1.7%
0.0%
1 Year
-46.86%
11.6%
0.0%
3 Years
-67.55%
12.9%
-18.1%

Quanterix Corporation Key Statistics

in dollars & INR

Market Capitalization
$475.9M
Revenue TTM
$129.3M
EBITDA
$-45.9M
Earnings Per Share (EPS)
$-1.04
Profit Margin
-30.71%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-11.48%

How to invest in Quanterix Corporation from India?

It is very easy for Indian residents to invest directly in Quanterix Corporation from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quanterix Corporation stock in both rupees (INR) and dollars (USD). Search for Quanterix Corporation or QTRX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quanterix Corporation or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quanterix Corporation shares which would translate to 0.072 fractional shares of Quanterix Corporation as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Quanterix Corporation

60%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Quanterix Corporation on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 60% more investors are searching Quanterix Corporation in the last 30 days versus the previous period.

Global Institutional Holdings in Quanterix Corporation

  • AllianceBernstein L.P.

    8.90%

  • BlackRock Inc

    8.17%

  • Vanguard Group Inc

    5.73%

  • Portolan Capital Management, LLC

    5.00%

  • Ameriprise Financial Inc

    3.41%

  • Granahan Investment Management Inc..

    2.87%

Analyst Recommendation on Quanterix Corporation

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Quanterix Corporation(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Quanterix Corporation

What analysts predicted

Upside of 69.04%

Current:

$11.79

Target:

$19.93

Insights on Quanterix Corporation

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 30.83M → 34.38M (in $), with an average increase of 3.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -12.40M → -9.47M (in $), with an average increase of 14.8% per quarter
  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 61.1% return, outperforming this stock by 111.7%
  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 129.2% return, outperforming this stock by 195.8%

Quanterix Corporation Financials in INR & Dollars

FY18Y/Y Change
Revenue
$37.6M
↑ 64.52%
Net Income
$-31.0M
↑ 14.9%
Net Profit Margin
-82.5%
↑ 35.62%
FY19Y/Y Change
Revenue
$56.7M
↑ 50.76%
Net Income
$-40.8M
↑ 31.41%
Net Profit Margin
-71.91%
↑ 10.59%
FY20Y/Y Change
Revenue
$86.4M
↑ 52.25%
Net Income
$-31.5M
↓ 22.71%
Net Profit Margin
-36.5%
↑ 35.41%
FY21Y/Y Change
Revenue
$110.6M
↑ 27.99%
Net Income
$-57.7M
↑ 82.96%
Net Profit Margin
-52.18%
↓ 15.68%
FY22Y/Y Change
Revenue
$105.0M
↓ 5.07%
Net Income
$-96.7M
↑ 67.63%
Net Profit Margin
-92.14%
↓ 39.96%
FY23Y/Y Change
Revenue
$122.4M
↑ 16.59%
Net Income
$-32.3M
↓ 66.56%
Net Profit Margin
-26.42%
↑ 65.72%
Q1 FY23Q/Q Change
Revenue
$28.2M
↑ 10.24%
Net Income
$-6.1M
↓ 67.19%
Net Profit Margin
-21.62%
↑ 51.01%
Q2 FY23Q/Q Change
Revenue
$30.9M
↑ 9.35%
Net Income
$-6.1M
↓ 0.64%
Net Profit Margin
-19.64%
↑ 1.98%
Q3 FY23Q/Q Change
Revenue
$30.8M
↓ 0.12%
Net Income
$-7.8M
↑ 27.94%
Net Profit Margin
-25.16%
↓ 5.52%
Q4 FY23Q/Q Change
Revenue
$31.5M
↑ 2.32%
Net Income
$-12.4M
↑ 59.95%
Net Profit Margin
-39.33%
↓ 14.17%
Q1 FY24Q/Q Change
Revenue
$32.1M
↑ 1.64%
Net Income
$-10.1M
↓ 18.83%
Net Profit Margin
-31.41%
↑ 7.92%
Q2 FY24Q/Q Change
Revenue
$34.4M
↑ 7.22%
Net Income
$-9.5M
↓ 5.95%
Net Profit Margin
-27.55%
↑ 3.86%
FY18Y/Y Change
Total Assets
$67.6M
↓ 26.31%
Total Liabilities
$26.1M
↑ 0.61%
FY19Y/Y Change
Total Assets
$170.0M
↑ 151.3%
Total Liabilities
$41.3M
↑ 58.38%
FY20Y/Y Change
Total Assets
$271.0M
↑ 59.48%
Total Liabilities
$64.9M
↑ 57.22%
FY21Y/Y Change
Total Assets
$501.5M
↑ 85.03%
Total Liabilities
$60.6M
↓ 6.69%
FY22Y/Y Change
Total Assets
$434.2M
↓ 13.42%
Total Liabilities
$75.3M
↑ 24.24%
FY23Y/Y Change
Total Assets
$425.0M
↓ 2.12%
Total Liabilities
$78.1M
↑ 3.75%
Q1 FY23Q/Q Change
Total Assets
$427.3M
↓ 1.59%
Total Liabilities
$70.0M
↓ 7.01%
Q2 FY23Q/Q Change
Total Assets
$429.2M
↑ 0.44%
Total Liabilities
$73.9M
↑ 5.53%
Q3 FY23Q/Q Change
Total Assets
$429.0M
↓ 0.04%
Total Liabilities
$75.7M
↑ 2.49%
Q4 FY23Q/Q Change
Total Assets
$425.0M
↓ 0.94%
Total Liabilities
$78.1M
↑ 3.16%
Q1 FY24Q/Q Change
Total Assets
$411.7M
↓ 3.12%
Total Liabilities
$70.3M
↓ 9.95%
Q2 FY24Q/Q Change
Total Assets
$411.3M
↓ 0.11%
Total Liabilities
$74.5M
↑ 6.01%
FY18Y/Y Change
Operating Cash Flow
$-28.7M
↑ 29.92%
Investing Cash Flow
$-5.5M
↑ 381.8%
Financing Cash Flow
$-78.0K
↓ 100.11%
FY19Y/Y Change
Operating Cash Flow
$-26.2M
↓ 8.82%
Investing Cash Flow
$-25.4M
↑ 365.27%
Financing Cash Flow
$116.2M
↓ 149070.51%
FY20Y/Y Change
Operating Cash Flow
$-23.4M
↓ 10.78%
Investing Cash Flow
$-626.0K
↓ 97.53%
Financing Cash Flow
$96.2M
↓ 17.18%
FY21Y/Y Change
Operating Cash Flow
$-47.9M
↑ 105.04%
Investing Cash Flow
$-6.3M
↑ 912.46%
Financing Cash Flow
$270.8M
↑ 181.39%
FY22Y/Y Change
Operating Cash Flow
$-48.3M
↑ 0.76%
Investing Cash Flow
$-11.2M
↑ 76.81%
Financing Cash Flow
$2.3M
↓ 99.15%
Q1 FY23Q/Q Change
Operating Cash Flow
$-9.5M
↑ 132.32%
Investing Cash Flow
$-136.0K
↓ 91.47%
Financing Cash Flow
$551.0K
↓ 22.83%
Q2 FY23Q/Q Change
Operating Cash Flow
$633.0K
↓ 106.66%
Investing Cash Flow
$-648.0K
↑ 376.47%
Financing Cash Flow
$139.0K
↓ 74.77%

Quanterix Corporation Technicals Summary

Sell

Neutral

Buy

Quanterix Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Quanterix Corporation Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Quanterix Corporation
-9.46%
-18.36%
-46.86%
-67.55%
-50.16%
Stryker Corporation
6.2%
12.61%
34.12%
53.15%
91.0%
Boston Scientific Corp.
6.74%
19.16%
64.78%
122.19%
105.15%
Edwards Lifesciences Corp.
6.11%
-19.0%
2.44%
-37.0%
-11.46%
Abbott Laboratories
-0.71%
13.16%
11.94%
-11.82%
36.65%
Medtronic Plc
-3.1%
5.14%
9.79%
-21.5%
-23.48%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Quanterix Corporation
NA
NA
NA
-0.97
-0.11
-0.08
NA
8.77
Stryker Corporation
42.03
42.03
2.74
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
74.93
74.93
1.64
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
27.55
27.55
6.52
2.53
0.19
0.11
NA
16.18
Abbott Laboratories
36.1
36.1
2.31
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
26.38
26.38
1.56
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Quanterix Corporation
Buy
$475.9M
-50.16%
NA
-30.71%
Stryker Corporation
Buy
$149.5B
91.0%
42.03
16.34%
Boston Scientific Corp.
Buy
$133.7B
105.15%
74.93
11.26%
Edwards Lifesciences Corp.
Buy
$42.5B
-11.46%
27.55
65.86%
Abbott Laboratories
Buy
$206.3B
36.65%
36.1
13.99%
Medtronic Plc
Buy
$110.6B
-23.48%
26.38
12.06%

About Quanterix Corporation

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Organization
Quanterix Corporation
Employees
441
CEO
Dr. Masoud Toloue Ph.D.
Industry
Health Technology

Important FAQs about investing in Quanterix Corporation from India :

What is Quanterix Corporation share price today?

Quanterix Corporation (QTRX) share price today is $11.79.

Can Indians buy Quanterix Corporation shares?

Yes, Indians can invest in the Quanterix Corporation (QTRX) from India.

With INDmoney, you can buy Quanterix Corporation at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Quanterix Corporation at zero transaction cost.

How can I buy Quanterix Corporation shares from India?

It is very easy to buy Quanterix Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quanterix Corporation be purchased?

Yes, you can buy fractional shares of Quanterix Corporation with INDmoney app.

What are the documents required to start investing in Quanterix Corporation stocks?

To start investing in Quanterix Corporation, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Quanterix Corporation

Today’s highest price of Quanterix Corporation (QTRX) is $12.50.

Today’s lowest price of Quanterix Corporation (QTRX) is $11.78.

What is today's market capitalisation of Quanterix Corporation

Today's market capitalisation of Quanterix Corporation QTRX is 475.9M

What is the 52 Week High and Low Range of Quanterix Corporation

  • 52 Week High

    $29.70

  • 52 Week Low

    $10.50

How much percentage Quanterix Corporation is down from its 52 Week High?

Quanterix Corporation (QTRX) share price is $11.79. It is down by 99% from its 52 Week High price of $29.70.

How much percentage Quanterix Corporation is up from its 52 Week low?

Quanterix Corporation (QTRX) share price is $11.79. It is up by 1% from its 52 Week Low price of $10.50.

What are the historical returns of Quanterix Corporation?

  • 1 Month Returns

    -9.46%

  • 3 Months Returns

    -18.36%

  • 1 Year Returns

    -46.86%

  • 5 Years Returns

    -50.16%

Who is the Chief Executive Officer (CEO) of Quanterix Corporation

Dr. Masoud Toloue Ph.D. is the current Chief Executive Officer (CEO) of Quanterix Corporation.